www.fdanews.com/articles/138546-synta-announces-first-patient-treated-in-the-galaxy-trial-a-phase-iib-iii-trial-for-ganetespib-in-advanced-2nd-line-non-small-cell-lung-cancer

Synta Announces First Patient Treated in the Galaxy Trial a Phase IIb/III Trial for Ganetespib in Advanced 2nd-line Non-small Cell Lung Cancer

July 20, 2011

Synta Pharmaceuticals announced that the first patient has been treated in a Phase IIb/III clinical trial of ganetespib in combination with docetaxel in non-small cell lung cancer.
MarketWatch